A multicenter, observational cohort study investigating safety and efficacy of telaprevir or simeprevir-based regimens in Italian patients with chronic hepatitis C infection

Trial Profile

A multicenter, observational cohort study investigating safety and efficacy of telaprevir or simeprevir-based regimens in Italian patients with chronic hepatitis C infection

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 May 2016

At a glance

  • Drugs Simeprevir (Primary) ; Telaprevir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Stily
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 10 May 2016 New trial record
    • 17 Apr 2016 Interim results (n= 338) assessing effectiveness presented at The International Liver Congress™ 2016
    • 17 Apr 2016 Interim results (n= 338) presented at The International Liver Congress 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top